Sylvester Researchers Identify DNA Marker That Could Predict Treatment Response in MDS
· newswise.com · popularity 21/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at newswise.com →
Summary
What if doctors could predict whether a cancer treatment will work before it begins? A new study from Sylvester Comprehensive Cancer Center identifies DNA methylation patterns that could help predict which patients with myelodysplastic syndromes (MDS) will respond to azacitidine, a commonly used therapy.
Found in: Newswise. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 1.